{"id":622,"date":"2022-04-25T21:13:46","date_gmt":"2022-04-25T21:13:46","guid":{"rendered":"https:\/\/newsletters.aans.org\/tumor\/?page_id=622"},"modified":"2022-04-26T13:49:30","modified_gmt":"2022-04-26T13:49:30","slug":"journal-of-neuro-oncology","status":"publish","type":"page","link":"https:\/\/newsletters.aans.org\/tumor\/tumor-news-spring-2022\/journal-of-neuro-oncology\/","title":{"rendered":"Journal of Neuro-Oncology"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter wp-image-623\" src=\"https:\/\/newsletters.aans.org\/wp-content\/uploads\/sites\/5\/2022\/04\/Journal-of-Neuro-Oncology-1.jpg\" alt=\"\" width=\"300\" height=\"450\" srcset=\"https:\/\/newsletters.aans.org\/wp-content\/uploads\/sites\/5\/2022\/04\/Journal-of-Neuro-Oncology-1.jpg 600w, https:\/\/newsletters.aans.org\/wp-content\/uploads\/sites\/5\/2022\/04\/Journal-of-Neuro-Oncology-1-200x300.jpg 200w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<p>&nbsp;<\/p>\n<p>The <u>Journal of Neuro-Oncology<\/u> (JNO) is the official journal of the AANS and CNS Tumor Section.\u00a0 Several other prominent organizations also help to sponsor the journal.\u00a0 These include the Radiosurgery Society (RSS), the Indian Society of Neuro-Oncology (ISNO), Chinese Society of Neuro-Oncology, European Association of Neurological Societies (EANS), the Grupo Interdisciplinario Mexicano de Investigacion en Neuro-Oncologia (GIMINO), the Korean Neurological Society, Society of British Neurological Surgeons (SBNS), Society of Neuro-Oncology Latin America (SNOLA), Pakistan Society of Neuro-Oncology (PASNO), and Taiwan Society for Neuro-Oncology (TSNO).\u00a0 It is published 15 times per year.<\/p>\n<p>The latest impact factor for the JNO is 4.13.\u00a0 Manuscript submissions increased again last year.<\/p>\n<p>Springer has introduced two options for members\u2019 access to the journal.\u00a0 A low priced rate for online access alone and a reasonable rate for both online and print access to JNO.<\/p>\n<p>Recent special issues for JNO include a recurrent glioblastoma guidelines one led by Dr. Jeff Olson.\u00a0 Also, a focused ultrasound special issue was completed by Drs. Michael Lim, Gordon Li, and Graeme Woodworth.\u00a0 Another special issue on adverse radiation effects is underway by Dr. Daniel Trifiletti and colleagues.\u00a0 Other special issues include one by Dr. Jennifer Moliterno on meningiomas and an issue focused on diagnostic and therapeutic implications of IDH mutations in gliomas led by Dr. Tareq Juratli.<\/p>\n<p>JNO was part of a special session at the 2021 CNS Annual meeting which was focused on contemporary practice and trends in neurosurgical academic publishing.\u00a0 We were part of the forum with <u>Neurosurgery<\/u> and other leading neurosurgical focused journals.\u00a0 This allowed new contributors to learn more about the academic publishing process.<\/p>\n<p>Social Media following for JNO has continued to grow.\u00a0 We currently have:<\/p>\n<p>Facebook\u00a0followers: 4432 (up from 2760 a year ago)<\/p>\n<p>Twitter\u00a0followers: 4228 (up from 2331 a year ago)<\/p>\n<p>Instagram\u00a0followers: 3874 (up from 1969 a year ago)<\/p>\n<p>&nbsp;<\/p>\n<p>Special thanks to Drs. Mehta and Shepard for their help with the JNO Social Media sites.\u00a0 Also, Randy D\u2019Amico continues the very popular JNO webinar series featured on Youtube.<\/p>\n<p>Thank you for the tremendous efforts provided by our outstanding reviewers, editorial board members, and associate editors.<\/p>\n<p><strong>For those interested in serving as a reviewer, please contact me.\u00a0 Also, ideas for JNO supplements and willingness to serve as a reviewer, associate editor or editor for a JNO would be most appreciated.\u00a0 I can be reached at <\/strong><a href=\"mailto:jsheehan@virginia.edu\"><strong>jsheehan@virginia.edu<\/strong><\/a><strong>.<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&nbsp; The Journal of Neuro-Oncology (JNO) is the official journal of the AANS and CNS Tumor Section.\u00a0 Several other prominent organizations also help to sponsor the journal.\u00a0 These include the Radiosurgery Society (RSS), the Indian Society of Neuro-Oncology (ISNO), Chinese Society of Neuro-Oncology, European Association of Neurological Societies (EANS), the Grupo Interdisciplinario Mexicano de Investigacion [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":623,"parent":596,"menu_order":6,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-622","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Journal of Neuro-Oncology - Tumor News<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/newsletters.aans.org\/tumor\/tumor-news-spring-2022\/journal-of-neuro-oncology\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Journal of Neuro-Oncology - Tumor News\" \/>\n<meta property=\"og:description\" content=\"&nbsp; The Journal of Neuro-Oncology (JNO) is the official journal of the AANS and CNS Tumor Section.\u00a0 Several other prominent organizations also help to sponsor the journal.\u00a0 These include the Radiosurgery Society (RSS), the Indian Society of Neuro-Oncology (ISNO), Chinese Society of Neuro-Oncology, European Association of Neurological Societies (EANS), the Grupo Interdisciplinario Mexicano de Investigacion [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/newsletters.aans.org\/tumor\/tumor-news-spring-2022\/journal-of-neuro-oncology\/\" \/>\n<meta property=\"og:site_name\" content=\"Tumor News\" \/>\n<meta property=\"article:modified_time\" content=\"2022-04-26T13:49:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/newsletters.aans.org\/wp-content\/uploads\/sites\/5\/2022\/04\/Journal-of-Neuro-Oncology-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/tumor-news-spring-2022\\\/journal-of-neuro-oncology\\\/\",\"url\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/tumor-news-spring-2022\\\/journal-of-neuro-oncology\\\/\",\"name\":\"Journal of Neuro-Oncology - Tumor News\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/tumor-news-spring-2022\\\/journal-of-neuro-oncology\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/tumor-news-spring-2022\\\/journal-of-neuro-oncology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/newsletters.aans.org\\\/wp-content\\\/uploads\\\/sites\\\/5\\\/2022\\\/04\\\/Journal-of-Neuro-Oncology-1.jpg\",\"datePublished\":\"2022-04-25T21:13:46+00:00\",\"dateModified\":\"2022-04-26T13:49:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/tumor-news-spring-2022\\\/journal-of-neuro-oncology\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/tumor-news-spring-2022\\\/journal-of-neuro-oncology\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/tumor-news-spring-2022\\\/journal-of-neuro-oncology\\\/#primaryimage\",\"url\":\"https:\\\/\\\/newsletters.aans.org\\\/wp-content\\\/uploads\\\/sites\\\/5\\\/2022\\\/04\\\/Journal-of-Neuro-Oncology-1.jpg\",\"contentUrl\":\"https:\\\/\\\/newsletters.aans.org\\\/wp-content\\\/uploads\\\/sites\\\/5\\\/2022\\\/04\\\/Journal-of-Neuro-Oncology-1.jpg\",\"width\":600,\"height\":900,\"caption\":\"Journal of Neuro Oncology\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/tumor-news-spring-2022\\\/journal-of-neuro-oncology\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tumor News Spring 2022\",\"item\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/tumor-news-spring-2022\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Journal of Neuro-Oncology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/#website\",\"url\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/\",\"name\":\"Tumor News\",\"description\":\"Just another AANS Newsletter Sites site\",\"publisher\":{\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/#organization\",\"name\":\"Tumor News\",\"url\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/newsletters.aans.org\\\/wp-content\\\/uploads\\\/sites\\\/5\\\/2024\\\/11\\\/JST.2024.logo_.png\",\"contentUrl\":\"https:\\\/\\\/newsletters.aans.org\\\/wp-content\\\/uploads\\\/sites\\\/5\\\/2024\\\/11\\\/JST.2024.logo_.png\",\"width\":2336,\"height\":2294,\"caption\":\"Tumor News\"},\"image\":{\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Journal of Neuro-Oncology - Tumor News","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/newsletters.aans.org\/tumor\/tumor-news-spring-2022\/journal-of-neuro-oncology\/","og_locale":"en_US","og_type":"article","og_title":"Journal of Neuro-Oncology - Tumor News","og_description":"&nbsp; The Journal of Neuro-Oncology (JNO) is the official journal of the AANS and CNS Tumor Section.\u00a0 Several other prominent organizations also help to sponsor the journal.\u00a0 These include the Radiosurgery Society (RSS), the Indian Society of Neuro-Oncology (ISNO), Chinese Society of Neuro-Oncology, European Association of Neurological Societies (EANS), the Grupo Interdisciplinario Mexicano de Investigacion [&hellip;]","og_url":"https:\/\/newsletters.aans.org\/tumor\/tumor-news-spring-2022\/journal-of-neuro-oncology\/","og_site_name":"Tumor News","article_modified_time":"2022-04-26T13:49:30+00:00","og_image":[{"width":600,"height":900,"url":"https:\/\/newsletters.aans.org\/wp-content\/uploads\/sites\/5\/2022\/04\/Journal-of-Neuro-Oncology-1.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/newsletters.aans.org\/tumor\/tumor-news-spring-2022\/journal-of-neuro-oncology\/","url":"https:\/\/newsletters.aans.org\/tumor\/tumor-news-spring-2022\/journal-of-neuro-oncology\/","name":"Journal of Neuro-Oncology - Tumor News","isPartOf":{"@id":"https:\/\/newsletters.aans.org\/tumor\/#website"},"primaryImageOfPage":{"@id":"https:\/\/newsletters.aans.org\/tumor\/tumor-news-spring-2022\/journal-of-neuro-oncology\/#primaryimage"},"image":{"@id":"https:\/\/newsletters.aans.org\/tumor\/tumor-news-spring-2022\/journal-of-neuro-oncology\/#primaryimage"},"thumbnailUrl":"https:\/\/newsletters.aans.org\/wp-content\/uploads\/sites\/5\/2022\/04\/Journal-of-Neuro-Oncology-1.jpg","datePublished":"2022-04-25T21:13:46+00:00","dateModified":"2022-04-26T13:49:30+00:00","breadcrumb":{"@id":"https:\/\/newsletters.aans.org\/tumor\/tumor-news-spring-2022\/journal-of-neuro-oncology\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/newsletters.aans.org\/tumor\/tumor-news-spring-2022\/journal-of-neuro-oncology\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/newsletters.aans.org\/tumor\/tumor-news-spring-2022\/journal-of-neuro-oncology\/#primaryimage","url":"https:\/\/newsletters.aans.org\/wp-content\/uploads\/sites\/5\/2022\/04\/Journal-of-Neuro-Oncology-1.jpg","contentUrl":"https:\/\/newsletters.aans.org\/wp-content\/uploads\/sites\/5\/2022\/04\/Journal-of-Neuro-Oncology-1.jpg","width":600,"height":900,"caption":"Journal of Neuro Oncology"},{"@type":"BreadcrumbList","@id":"https:\/\/newsletters.aans.org\/tumor\/tumor-news-spring-2022\/journal-of-neuro-oncology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/newsletters.aans.org\/tumor\/"},{"@type":"ListItem","position":2,"name":"Tumor News Spring 2022","item":"https:\/\/newsletters.aans.org\/tumor\/tumor-news-spring-2022\/"},{"@type":"ListItem","position":3,"name":"Journal of Neuro-Oncology"}]},{"@type":"WebSite","@id":"https:\/\/newsletters.aans.org\/tumor\/#website","url":"https:\/\/newsletters.aans.org\/tumor\/","name":"Tumor News","description":"Just another AANS Newsletter Sites site","publisher":{"@id":"https:\/\/newsletters.aans.org\/tumor\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/newsletters.aans.org\/tumor\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/newsletters.aans.org\/tumor\/#organization","name":"Tumor News","url":"https:\/\/newsletters.aans.org\/tumor\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/newsletters.aans.org\/tumor\/#\/schema\/logo\/image\/","url":"https:\/\/newsletters.aans.org\/wp-content\/uploads\/sites\/5\/2024\/11\/JST.2024.logo_.png","contentUrl":"https:\/\/newsletters.aans.org\/wp-content\/uploads\/sites\/5\/2024\/11\/JST.2024.logo_.png","width":2336,"height":2294,"caption":"Tumor News"},"image":{"@id":"https:\/\/newsletters.aans.org\/tumor\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/pages\/622","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/comments?post=622"}],"version-history":[{"count":1,"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/pages\/622\/revisions"}],"predecessor-version":[{"id":624,"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/pages\/622\/revisions\/624"}],"up":[{"embeddable":true,"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/pages\/596"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/media\/623"}],"wp:attachment":[{"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/media?parent=622"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}